A consortium led by state-owned pharma giant Sinopharm has revived a take-private bid for China Traditional Chinese Medicine Holdings, the Hong Kong-listed drugmaker said on Wednesday, valuing it at HK$23.16 billion ($2.96 billion).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
